Search Results - "Levy, R A"

Refine Results
  1. 1

    Geographic trends in incidence of hip fractures: a comprehensive literature review by Cheng, S. Y., Levy, A. R, Lefaivre, K. A., Guy, P., Kuramoto, L., Sobolev, B.

    Published in Osteoporosis international (01-10-2011)
    “…Summary A comprehensive review of literature was conducted to investigate variation in hip fracture incident rates around the world. The original crude…”
    Get full text
    Journal Article
  2. 2

    The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes by Lane, S., Levy, A. R., Mukherjee, J., Sambrook, J., Tildesley, H.

    Published in Current medical research and opinion (01-07-2014)
    “…Abstract Objective: The objective of this study was to estimate utility values for hypothetical health states that describe differences in weight and quality…”
    Get full text
    Journal Article
  3. 3

    Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus by Wallace, DJ, Navarra, S, Petri, MA, Gallacher, A, Thomas, M, Furie, R, Levy, RA, van Vollenhoven, RF, Cooper, S, Zhong, ZJ, Freimuth, W, Cervera, R

    Published in Lupus (01-02-2013)
    “…Safety data were pooled and analyzed from one phase 2 and two phase 3 double-blind, placebo-controlled, repeat-dose systemic lupus erythematosus (SLE) trials…”
    Get full text
    Journal Article
  4. 4

    Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review by Sciascia, S, Radin, M, Yazdany, J, Levy, RA, Roccatello, D, Dall'Era, M, Cuadrado, Maria J

    Published in Autoimmunity reviews (01-03-2017)
    “…Abstract Both BLISS-52 and BLISS-76 international phase III trials in Systemic Lupus Erythematosus (SLE) met their primary outcomes; however, they were not…”
    Get full text
    Journal Article
  5. 5

    Pre-competitive confidence, coping, and subjective performance in sport by Levy, A. R., Nicholls, A. R., Polman, R. C. J.

    “…The primary aim of this study was to investigate the relationship between confidence and subjective performance in addition to exploring whether coping…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Societal preference values for advanced melanoma health states in the United Kingdom and Australia by Beusterien, K M, Szabo, S M, Kotapati, S, Mukherjee, J, Hoos, A, Hersey, P, Middleton, M R, Levy, A R

    Published in British journal of cancer (04-08-2009)
    “…Background: No studies measure preference-based utilities in advanced melanoma that capture both intended clinical response and unintended toxicities…”
    Get full text
    Journal Article
  9. 9

    Functional Contrast-Enhanced CT for Evaluation of Acute Ischemic Stroke Does Not Increase the Risk of Contrast-Induced Nephropathy by LIMA, F. O, LEV, M. H, GONZALEZ, R. Gilberto, KOROSHETZ, W. J, SMITH, W. S, FURIE, K. L, LEVY, R. A, SILVA, G. S, EBRIL, M, DE CAMARGO, E. C, POMERANTZ, S, SINGHAL, A. B, GREER, D. M, AY, H

    Published in American journal of neuroradiology : AJNR (01-05-2010)
    “…Concerns have recently grown regarding the safety of iodinated contrast agents used for CTA and CTP imaging. We tested whether the incidence of AN, defined by…”
    Get full text
    Journal Article
  10. 10

    Patient–health care provider relationship: how can it impact on APS (Hughes’ syndrome) adherence to treatment? by Levy, RA, Signorelli, F

    Published in Lupus (01-10-2014)
    “…Adherence to treatment is fundamental for its success. It comprises compliance combined with persistency and should be constantly reassessed. This is true in…”
    Get full text
    Journal Article
  11. 11

    Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study by Levy, R A, Vilela, V S, Cataldo, M J, Ramos, R C, Duarte, J LMB, Tura, B R, Albuquerque, E MN, Jesús, N R

    Published in Lupus (01-06-2001)
    “…We conducted a randomized, controlled study to assess the need for hydroxychloroquine (HCQ) during lupus pregnancy and to assess safety. Twenty consecutive…”
    Get full text
    Journal Article
  12. 12

    PO.5.102 Pharmacokinetic modelling of belimumab in patients with lupus nephritis: intravenous and subcutaneous loading dose regimen justification by Parodis, I, Liefaard, L, Green, Y, Gilbride, JA, Henning, C, Levy, RA, Dimelow, R

    Published in Lupus science & medicine (01-10-2022)
    “…PurposeIntravenous (IV) belimumab (BEL) is approved for lupus nephritis (LN) based on the BLISS-LN study (GSK Study BEL114054, NCT01639339), which showed that…”
    Get full text
    Journal Article
  13. 13

    Simplified Bayesian Sensitivity Analysis for Mismeasured and Unobserved Confounders by Gustafson, P., McCandless, L. C., Levy, A. R., Richardson, S.

    Published in Biometrics (01-12-2010)
    “…Summary We examine situations where interest lies in the conditional association between outcome and exposure variables, given potential confounding variables…”
    Get full text
    Journal Article
  14. 14

    PO.5.105 The effect of belimumab on extra-renal outcomes: results from the phase 3, randomised, placebo-controlled, 104-week bliss-ln study in patients with active lupus nephritis by Weinmann-Menke, J, Okada, M, Arriens, C, Jones-Leone, A, Levy, RA, Gilbride, JA, Furie, R, Yang, N

    Published in Lupus science & medicine (01-10-2022)
    “…PurposeThe effect of belimumab (BEL) on renal outcomes has been previously demonstrated in the BLISS-LN study in patients with active lupus nephritis (LN).1…”
    Get full text
    Journal Article
  15. 15

    PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis by Andreoli, L, Amoura, Z, Morales, E, Jones-Leone, A, Levy, RA, Gilbride, JA, Carnarius, H, Korsten, P

    Published in Lupus science & medicine (01-10-2022)
    “…PurposeTo evaluate the efficacy and safety of intravenous (IV) belimumab (BEL) in the European subgroup of patients with lupus nephritis (LN) from the…”
    Get full text
    Journal Article
  16. 16

    A simulation study of scheduling clinic appointments in surgical care: individual surgeon versus pooled lists by Vasilakis, C, Sobolev, B G, Kuramoto, L, Levy, A R

    “…The purpose of this paper is to compare two methods of scheduling outpatient clinic appointments in the setting where the availability of surgeons for…”
    Get full text
    Journal Article
  17. 17

    The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis by de Jesus, GR, de Jesus, NR, Levy, RA, Klumb, EM

    Published in Lupus (01-10-2014)
    “…Pre-eclampsia (PE) is a major cause of maternal mortality and morbidity, perinatal deaths, preterm birth and intrauterine growth restriction. Differential…”
    Get full text
    Journal Article
  18. 18

    Electrostatic flexible film based smart window: Optical design, performance and residual charge investigation by Yi, Xiuqiang, Su, Ke, Schlam, E., Levy, R.A.

    Published in Solar energy (01-12-2014)
    “…•We develop a new type of dynamic polymeric window shade (smart window).•We investigate dielectric layer thickness dependence of operating voltage.•We…”
    Get full text
    Journal Article
  19. 19

    Changes in first hip fracture rates in British Columbia Canada, 1990–2004 by Lefaivre, K. A., Levy, A. R., Sobolev, B., Cheng, S. Y., Kuramoto, L., Guy, P.

    Published in Osteoporosis international (01-11-2011)
    “…Summary We determined age-standardized first hip fracture rates in British Columbia between 1990 and 2004. We found sex and fracture type rates in keeping with…”
    Get full text
    Journal Article
  20. 20

    Synthesis and characterization of plasma assisted chemically vapor deposited tantalum by Suh, Y., Chen, W., Maeng, S., Gu, S., Levy, R.A., Thridandam, H.

    Published in Thin solid films (30-07-2010)
    “…This study focuses on the synthesis of tantalum (Ta) coatings on high strength steel by plasma assisted chemical vapor deposition using tantalum pentachloride…”
    Get full text
    Journal Article